Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sefina Arif

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Current Opinion in Endocrinology, Diabetes, and Obesity|July 4, 2020
Assessing effector T cells in type 1 diabetesSefina Arif, Irma Pujol-Autonell, Martin Eichmann
Journal of Autoimmunity|September 8, 2015
T cells in type 1 diabetes: Instructors, regulators and effectors: A comprehensive reviewIria Gomez-Tourino, Sefina Arif, Martin Eichmann, et al.
Journal of Virology|November 27, 2004
Identification of a naturally processed cytotoxic CD8 T-cell epitope of coxsackievirus B4, presented by HLA-A2.1 and located in the PEVKEK region of the P2C nonstructural proteinRuben Varela-Calvino, Ania Skowera, Sefina Arif, et al.
Frontiers in Immunology|June 7, 2023
Monitoring islet specific immune responses in type 1 diabetes clinical immunotherapy trialsSefina Arif, Clara Domingo-Vila, Emily Pollock, et al.
Lancet (London, England)|July 9, 2010
Anti-TNFalpha therapy--killing two birds with one stone?Sefina Arif, Patricia Cox, Behdad Afzali, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 28, 2022
Evaluating T cell responses prior to the onset of type 1 diabetesSefina Arif, Norkhairin Yusuf, Clara Domingo-Vila, et al.
Diabetologia|October 16, 2019
Proinsulin peptide promotes autoimmune diabetes in a novel HLA-DR3-DQ2-transgenic murine model of spontaneous diseaseJohan Verhagen, Norkhairin Yusuf, Emma L Smith, et al.
Diabetes|March 20, 2010
Naturally arising human CD4 T-cells that recognize islet autoantigens and secrete interleukin-10 regulate proinflammatory T-cell responses via linked suppressionTimothy I M Tree, Jennifer Lawson, Hannah Edwards, et al.
The New England Journal of Medicine|March 7, 2009
Rituximab and omalizumab in severe, refractory insulin allergyPatrick F K Yong, Rifat Malik, Sefina Arif, et al.
Immunity|November 17, 2016
Targeting of Tumor-Associated Glycoforms of MUC1 with CAR T CellsJohn Maher, Scott Wilkie, David M Davies, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Current Opinion in Endocrinology, Diabetes, and Obesity|July 4, 2020
Assessing effector T cells in type 1 diabetesSefina Arif, Irma Pujol-Autonell, Martin Eichmann
Journal of Autoimmunity|September 8, 2015
T cells in type 1 diabetes: Instructors, regulators and effectors: A comprehensive reviewIria Gomez-Tourino, Sefina Arif, Martin Eichmann, et al.
Journal of Virology|November 27, 2004
Identification of a naturally processed cytotoxic CD8 T-cell epitope of coxsackievirus B4, presented by HLA-A2.1 and located in the PEVKEK region of the P2C nonstructural proteinRuben Varela-Calvino, Ania Skowera, Sefina Arif, et al.
Frontiers in Immunology|June 7, 2023
Monitoring islet specific immune responses in type 1 diabetes clinical immunotherapy trialsSefina Arif, Clara Domingo-Vila, Emily Pollock, et al.
Lancet (London, England)|July 9, 2010
Anti-TNFalpha therapy--killing two birds with one stone?Sefina Arif, Patricia Cox, Behdad Afzali, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 28, 2022
Evaluating T cell responses prior to the onset of type 1 diabetesSefina Arif, Norkhairin Yusuf, Clara Domingo-Vila, et al.
Diabetologia|October 16, 2019
Proinsulin peptide promotes autoimmune diabetes in a novel HLA-DR3-DQ2-transgenic murine model of spontaneous diseaseJohan Verhagen, Norkhairin Yusuf, Emma L Smith, et al.
Diabetes|March 20, 2010
Naturally arising human CD4 T-cells that recognize islet autoantigens and secrete interleukin-10 regulate proinflammatory T-cell responses via linked suppressionTimothy I M Tree, Jennifer Lawson, Hannah Edwards, et al.
The New England Journal of Medicine|March 7, 2009
Rituximab and omalizumab in severe, refractory insulin allergyPatrick F K Yong, Rifat Malik, Sefina Arif, et al.
Immunity|November 17, 2016
Targeting of Tumor-Associated Glycoforms of MUC1 with CAR T CellsJohn Maher, Scott Wilkie, David M Davies, et al.
Pageof 3